Coming Soon
The Key to Policy Change
David Brailer of Health Evolution sits down with Mark McClellan of the Duke-Margolis Center for Health Policy to dive deep into the next iteration of the value equation to include prescription drugs, devices and gene therapies.
David Brailer, MD, PhD
Executive ChairmanHealth Evolution
David J. Brailer, MD, PhD, has served as a member of the Walgreen Co. board of directors since 2010. He is Managing Partner & CEO of Health Evolution Partners. David J. Brailer, M.D., Ph.D. is widely known as the health care industry's champion of innovation. Over the past two decades, he has shaped the evolution of health care through his work as a physician, researcher, educator, entrepreneur, policymaker and investor Full bio ›
Mark McClellan, MD, PhD
Director, Duke-Margolis Center for Health Policy & Robert J. Margolis, M.D., Professor of Business, Medicine and PolicyMark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Health Policy, and Director of the Duke-Margolis Center for Health Policy at Duke University with offices at Duke and in Washington DC. The new Center will support and conduct research, evaluation, implementation, and educational activities to improve health policy and health, through collaboration across Duke University and Health System, Full bio ›
related interviews
Incompatible Policy Solutions
Molly Coye, MD + Ron WilliamsMolly Coye of Avia and Ron Williams formerly of Aetna discuss robust strategies to make care more affordable over the long term.
Reform: A Question of the Government's Role
Governor Mike LeavittChairman & Founder, Leavitt Partners;
former Secretary, Department of Health and Human Services
Governor Mike Leavitt, Chairman and Founder of Leavitt Partners and a former HHS Secretary, shares how reform is ultimately a debate of our values and the role that we want the government to play in our lives.
Expectations Ahead
Peter OrszagManaging Director & Vice Chairman of Investment Banking, Lazard
Former Director, Office of Management and Budget
Former Director, Congressional Budget Office
Peter Orszag, former Director of the Office of Management and Budget and the Congressional Budget Office, shares insights on what we’ve learned from the Affordable Care Act and expectations for payment models ahead.
